1. Home
  2. GRFS vs FCN Comparison

GRFS vs FCN Comparison

Compare GRFS & FCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRFS
  • FCN
  • Stock Information
  • Founded
  • GRFS 1940
  • FCN 1982
  • Country
  • GRFS Spain
  • FCN United States
  • Employees
  • GRFS N/A
  • FCN N/A
  • Industry
  • GRFS Biotechnology: Pharmaceutical Preparations
  • FCN Professional Services
  • Sector
  • GRFS Health Care
  • FCN Consumer Discretionary
  • Exchange
  • GRFS Nasdaq
  • FCN Nasdaq
  • Market Cap
  • GRFS 6.2B
  • FCN 5.6B
  • IPO Year
  • GRFS 2006
  • FCN 1996
  • Fundamental
  • Price
  • GRFS $10.10
  • FCN $174.22
  • Analyst Decision
  • GRFS Hold
  • FCN Hold
  • Analyst Count
  • GRFS 1
  • FCN 2
  • Target Price
  • GRFS $10.30
  • FCN $175.50
  • AVG Volume (30 Days)
  • GRFS 1.1M
  • FCN 373.0K
  • Earning Date
  • GRFS 01-01-0001
  • FCN 07-24-2025
  • Dividend Yield
  • GRFS N/A
  • FCN N/A
  • EPS Growth
  • GRFS N/A
  • FCN N/A
  • EPS
  • GRFS 0.31
  • FCN 7.09
  • Revenue
  • GRFS $7,968,532,207.00
  • FCN $3,662,887,000.00
  • Revenue This Year
  • GRFS $7.14
  • FCN $0.23
  • Revenue Next Year
  • GRFS $7.16
  • FCN $7.09
  • P/E Ratio
  • GRFS $41.40
  • FCN $24.57
  • Revenue Growth
  • GRFS 10.76
  • FCN N/A
  • 52 Week Low
  • GRFS $6.19
  • FCN $151.75
  • 52 Week High
  • GRFS $10.30
  • FCN $243.60
  • Technical
  • Relative Strength Index (RSI)
  • GRFS 67.23
  • FCN 67.98
  • Support Level
  • GRFS $9.66
  • FCN $162.46
  • Resistance Level
  • GRFS $10.30
  • FCN $176.99
  • Average True Range (ATR)
  • GRFS 0.26
  • FCN 3.18
  • MACD
  • GRFS 0.00
  • FCN 0.93
  • Stochastic Oscillator
  • GRFS 85.19
  • FCN 80.94

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About FCN FTI Consulting Inc.

FTI Consulting Inc is a firm that generates its sales by providing professional business advisory services to customers. The company operates through five segments, namely corporate finance, forensic and litigation consulting, economic consulting, technology, and strategic communications. The company generates the majority of its revenue from the Corporate finance segment. Customers of the company come from a wide array of sectors, including construction, energy and power, environmental, financial institutions, healthcare and life science, insurance, real estate and infrastructure, retail and consumer products, telecom, media, and technology. The majority of the company's revenue is derived from serving customers in the United States.

Share on Social Networks: